Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Middle East Health Journal.
Press releases published on April 22, 2025
InnovAge to Announce Fiscal Third Quarter 2025 Financial Results and Host Conference Call Tuesday, May 6, 2025
GlobeNewswire
·
April 22, 2025
DENVER, April 22, 2025 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (“InnovAge” or the “Company”) (Nasdaq: INNV), an industry leader in providing comprehensive healthcare programs to frail, and predominantly dual-eligible seniors through the Program of All- …
MBX Biosciences to Participate in Citizens and RBC May Investor Conferences
GlobeNewswire
·
April 22, 2025
CARMEL, Ind., April 22, 2025 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic …
Cronos Unveils New Spinach® 1.2g Vapes and SOURZ by Spinach® Gummies Enhanced with Rare Cannabinoids
GlobeNewswire
·
April 22, 2025
TORONTO, April 22, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc.’s (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) best-selling cannabis brand, Spinach®, is thrilled to introduce three all-new 1.2g vape products, each expertly crafted with premium THC …
FluidForm Bio™ Strengthens IP Portfolio with Newly Issued Patent on Key Aspects of its Proprietary FRESH™ Platform
GlobeNewswire
·
April 22, 2025
WALTHAM, Mass., April 22, 2025 (GLOBE NEWSWIRE) -- FluidForm Bio™, a leader in cell therapies for chronic diseases such as type 1 diabetes, today announced that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. 12,215,202 B2, …
Cellphire Therapeutics Announces CRYPTICS Phase 2/3 Clinical Study Stopped Early for Efficacy Following Pre-Planned Interim Analysis by Independent Data Monitoring Committee (IDMC)
GlobeNewswire
·
April 22, 2025
CRYPTICS study met the primary efficacy endpoint to demonstrate statistical non-inferiority of the cryopreserved CLPH-511 platelet product to the standard of care room temperature control platelet product (RTP) with a one-sided significance level less than …
Join Calidi Biotherapeutics’ Exclusive Live Investor Webinar and Q&A Session on April 24
GlobeNewswire
·
April 22, 2025
SAN DIEGO, April 22, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company developing a new generation of targeted antitumor virotherapies, is pleased to invite investors to a webinar …
Ocean Biomedical Expands into Energy and Digital Asset Sectors to Accelerate Growth and Shareholder Value
GlobeNewswire
·
April 22, 2025
Strategic diversification into power infrastructure and cryptocurrencies supports long-term biopharma innovation PROVIDENCE, R.I., April 22, 2025 (GLOBE NEWSWIRE) -- Ocean Biomedical, Inc. (NASDAQ: OCEA), a biopharmaceutical company focused on pioneering …
Emergent BioSolutions to Report First Quarter 2025 Financial Results on May 7, 2025
GlobeNewswire
·
April 22, 2025
GAITHERSBURG, Md., April 22, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Wednesday, May 7, 2025, at 5:00 pm eastern time to discuss the financial results for the first quarter of 2025. Participants can …
Best Female Libido Boosters 2025 and Sexual Enhancement Pills for Women - By Oh Yes
GlobeNewswire
·
April 22, 2025
Rhyl, Wales, April 22, 2025 (GLOBE NEWSWIRE) -- A healthy sex life plays an important role in a woman's relationships, mental health, and confidence. However, nearly 1 in 3 women have sexual problems that can erode intimacy such as low libido, vaginal …
Aveanna to Participate at the Bank of America Securities 2025 Health Care Conference
GlobeNewswire
·
April 22, 2025
ATLANTA, April 22, 2025 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (“Aveanna”) (NASDAQ: AVAH) today announced that its management team will attend the Bank of America Securities 2025 Health Care Conference in Las Vegas on May 14, 2025. Management …
BriaCell Enrollment Pace Accelerating in Phase 3 Clinical Study in Advanced Metastatic Breast Cancer (Bria-ABC)
GlobeNewswire
·
April 22, 2025
Over 75 patients enrolled in BriaCell’s pivotal Phase 3 study of Bria-IMT™ plus immune check point inhibitor in metastatic breast cancer (MBC) 54 clinical sites across 15 states currently enrolling patients including Sylvester Comprehensive Cancer Center, …
BridgeBio to Host First Quarter 2025 Financial Results Conference Call on Tuesday, April 29, 2025 at 4:30 pm ET
GlobeNewswire
·
April 22, 2025
PALO ALTO, Calif., April 22, 2025 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a new type of biopharmaceutical company focused on genetic diseases, today announced that it will release its first quarter …
Palvella Therapeutics Granted Additional U.S. Patent for QTORIN™ Rapamycin for the Treatment of Microcystic Lymphatic Malformations
GlobeNewswire
·
April 22, 2025
Fifth issued patent in the U.S. for QTORIN™ rapamycin with anticipated patent life extending into 2038 QTORIN™ rapamycin has the potential to be the first approved therapy and standard of care for microcystic lymphatic malformations in the U.S. WAYNE, Pa., …
Lifecore Biomedical to Participate at Upcoming CDMO Live 2025 Conference
GlobeNewswire
·
April 22, 2025
CHASKA, Minn., April 22, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that the company will participate in the upcoming CDMO …
EDAP Announces Significant Presence of Focal One® at the Upcoming 120th American Urological Association (AUA) Annual Meeting
GlobeNewswire
·
April 22, 2025
Activities to include expert-led demonstrations, semi-live Focal One procedures and hands-on simulations Final results of randomized clinical trial (FARP Study) comparing ultrasound-based focal ablation versus radical prostatectomy as a first-line …
PolyPid to Participate in The Citizens Life Sciences Conference
GlobeNewswire
·
April 22, 2025
PETACH TIKVA, Israel, April 22, 2025 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD), (“PolyPid” or the “Company”), a late-stage biopharma company aiming to improve surgical outcomes, today announced that the Company’s management will participate in a …
Stereotaxis to Report First Quarter 2025 Financial Results on May 12, 2025
GlobeNewswire
·
April 22, 2025
ST. LOUIS, April 22, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will release financial results for its 2025 first quarter on …
Kymera Therapeutics Announces First Patient Dosed in BROADEN Phase 1b Atopic Dermatitis Clinical Trial of KT-621, a First-in-Class Oral STAT6 Degrader
GlobeNewswire
·
April 22, 2025
Data from the BroADen Phase 1b atopic dermatitis (AD) patient trial expected to be reported in 4Q25 Completed SAD/MAD dosing in KT-621 Phase 1 healthy volunteer trial with data to be reported in June 2025 Two parallel Phase 2b trials in AD and asthma …
InStride’s Hybrid Clinical Cohorts Fill High-Need Roles in Healthcare
GlobeNewswire
·
April 22, 2025
LOS ANGELES, April 22, 2025 (GLOBE NEWSWIRE) -- InStride, a human capital management company providing strategic education benefits, today announced a hybrid education model that empowers healthcare organizations to fill critical roles by developing talent …
Axsome Therapeutics to Participate in Upcoming Investor Conferences
GlobeNewswire
·
April 22, 2025
NEW YORK, April 22, 2025 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced that it will participate in four upcoming …